Loading market dashboard
INLIF Limited
INLFIndustrialsNASDAQCN
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
QUANZHOU, China, April 29, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that the Company has received a letter (the “Compliance Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2).
QUANZHOU, China, April 29, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that the Company has received a letter (the "Compliance Letter") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum bid price requirement of $1.
Utah Medical Products (NASDAQ: UTMD - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Analyst Recommendations This is a breakdown of
Sanuwave Health (NASDAQ: SNWV - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership. Insider and Institutional Ownership 42.5% of Sanuwave Health
QUANZHOU, China, March 31, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that its Board of Directors has approved a 1-for-16 share combination of all its authorized and issued ordinary shares, including both Class A ordinary shares and Class B ordinary shares (the “Share Combination”), pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 9, 2026 (the “EGM”).
